Childhood Cancer

You are here

Home » Grants » All grants tagged with "Juvenile Myelomonocytic Leukemia (JMML)"

All grants tagged with "Juvenile Myelomonocytic Leukemia (JMML)"

MYST acetyltransferases as a targetable dependency in JMML
Julia Maxson, PhD.
Oregon Health & Science University
R Accelerated Award Grants, Awarded 2025
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM
Robert Bowman, PhD
University of Pennsylvania
RARE Grant Program (Research Accelerating RUNX1 Exploration), Awarded 2024
Targeting Novel Inflammatory Signaling Pathways in Juvenile Myelomonocytic Leukemia
Santhosh Kumar Pasupuleti, PhD
Indiana University
'A' Award Grants, Awarded 2024
CLL-1 CAR-T cells with or without trametinib for the treatment of JMML
Elliot Stieglitz, MD
The Regents of the University of California San Francisco
R Accelerated Award Grants, Awarded 2023
Targeting Oncogenic RAS in Pediatric Leukemia
Loren Walensky, MD/PhD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2018
Role of Polycomb Repressive Complex 2 (PRC2) Mutations in Juvenile Myelomonocytic Leukemia
Emily Young
Boston Children’s Hospital
POST Program Grants, Awarded 2017
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia
Elliot Stieglitz, MD
University of California San Francisco
Young Investigator Grants, Awarded 2015
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia
Alan Cantor, MD/PhD
Boston Children’s Hospital
Innovation Grants, Awarded 2015
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells
Mitchell Weiss, MD/PhD
Children’s Hospital of Philadelphia
Innovation Grants, Awarded 2014
Investigating therapeutic strategies for JMML: a screen of kinase inhibitors to reveal potential therapeutic strategies and inform future efforts to address aberrant signal transduction.
Wan Xing Hong
University of California San Francisco
POST Program Grants, Awarded 2012

Pages

All childhood cancer types

Featured Hero

August Daniels

At 15 months old, August was diagnosed with bilateral retinoblastoma. By the time her family found out, she was basically blind. ALSF's Travel For Care program helped August get to the treatments she needed, and today she is 3 years old and can see!
Read more »